Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(γ-glutamic acid) nanoparticles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(γ-glutamic acid) nanoparticles

Published:2012-09 Issue:26 Volume:33 Page:6230-6239
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Broos Sissela,Sandin Linda C.,Apel Jenny,Tötterman Thomas H.,Akagi Takami,Akashi Mitsuru,Borrebaeck Carl A.K.,Ellmark Peter,Lindstedt Malin

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference53 articles.

1. The three Es of cancer immunoediting;Dunn;Annu Rev Immunol,2004

2. Cancer immunotherapy and nanomedicine;Sheng;Pharm Res,2011

3. CD40 stimulation leads to effective therapy of CD40(−) tumors through induction of strong systemic cytotoxic T lymphocyte immunity;van Mierlo;Proc Natl Acad Sci U S A,2002

4. T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibody;Tutt;J Immunol,2002

5. Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody;Vonderheide;J Clin Oncol,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation CD40 agonists for cancer immunotherapy;Expert Opinion on Biological Therapy;2024-05-03

2. Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination;Journal of Controlled Release;2023-10

3. Mannan and anti-CD40 antibody decorated and tumor antigen, CpG and Poly I:C encapsulated poly lactic-co- glycolic acid (PLGA) nanoparticles loaded dendritic cells induced type I immune responses against prostate cancer ex vivo;2023-07-21

4. Polymeric nanoparticle-based nanovaccines for cancer immunotherapy;Materials Horizons;2023

5. Cytokine Therapy Combined with Nanomaterials Participates in Cancer Immunotherapy;Pharmaceutics;2022-11-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3